Cidara Therapeutics Stock (NASDAQ: CDTX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 10.019K / 746.649K |
Day Range | - - - |
52 Wk Range | 0.500 - 1.480 |
Market Cap | $52.106M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 0.22% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cidara Therapeutics (NASDAQ: CDTX) through any online brokerage.
Other companies in Cidara Therapeutics’s space includes: Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Immuneering (NASDAQ:IMRX), Bolt Biotherapeutics (NASDAQ:BOLT) and BioLine Rx (NASDAQ:BLRX).
The latest price target for Cidara Therapeutics (NASDAQ: CDTX) was reported by HC Wainwright & Co. on Monday, April 8, 2024. The analyst firm set a price target for 6.00 expecting CDTX to rise to within 12 months (a possible 943.48% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Cidara Therapeutics (NASDAQ: CDTX) is $0.575 last updated Today at April 23, 2024 at 6:30 AM EDT.
There are no upcoming dividends for Cidara Therapeutics.
Cidara Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
The stock split for CDTX was announced on Monday, April 22, 2024. The date this stock split will start trading, also known as the ex-date, will be on Wednesday, April 24, 2024.
Cidara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.